Diagnosis Code: E88.1

Short Description: Lipodystrophy, not elsewhere classified

Long Description: Lipodystrophy, not elsewhere classified

The code E88.1 is VALID for claim submission

Code Classification:

• Endocrine, nutritional and metabolic diseases (E00–E89)
  • Metabolic disorders (E70-E88)
    • Other and unspecified metabolic disorders (E88)
      • E88.1 Lipodystrophy, not elsewhere classified

Code Version: 2022 ICD-10-CM

Synonyms

• Acquired generalized lipodystrophy
• Acquired partial lipodystrophy
• Acquired partial lipodystrophy
• Acquired partial lipodystrophy
• Adverse reaction following injection of substance
• Adverse reaction following injection of substance
• Adverse reaction following injection of substance
• AKT2-related familial partial lipodystrophy
• Autosomal semi-dominant severe lipodystrophic laminopathy
• CIDEC-related familial partial lipodystrophy
• Congenital abnormal shape of clavicle
• Congenital abnormal shape of clavicle
• Congenital anomaly of subcutaneous tissue
• Congenital anomaly of subcutaneous tissue
• Congenital anomaly of subcutaneous tissue
• Congenital anomaly of subcutaneous tissue
• Congenital deformity of clavicle
• Congenital deformity of clavicle
• Congenital deformity of shoulder
• Congenital deformity of shoulder
• Congenital generalized lipodystrophy
• Congenital generalized lipodystrophy
• Congenital generalized lipodystrophy
• Diabetes mellitus due to genetic defect in insulin action
• Familial partial lipodystrophy
• Familial partial lipodystrophy Dunnigan type
• Familial partial lipodystrophy Kobberling type
• Generalized congenital lipodystrophy with myopathy
• Genetic lipodystrophy
• Glucose-galactose malabsorption
• Glucose-galactose malabsorption
• Insulin adverse reaction
• Insulin lipoatrophy
• Insulin resistance
• Insulin resistance
• Keppen Lubinsky syndrome
• LIPE-related familial partial lipodystrophy
• Lipoatrophic diabetes
• Lipoatrophy
• Lipoatrophy and lipodystrophy
• Lipoatrophy caused by antiretroviral drug
• Lipoatrophy due to injected corticosteroid
• Lipoatrophy due to injected drug
• Lipoatrophy due to injected drug
• Lipoatrophy due to injected drug
• Lipodystrophia centrifugalis abdominalis infantalis
• Lipodystrophy
• Lipodystrophy caused by antiretroviral drug
• Lipodystrophy due to juvenile dermatomyositis
• Lipodystrophy due to peptidic growth factors deficiency
• Lipodystrophy of face
• Lipodystrophy, intellectual disability, deafness syndrome
• Lipodystrophy, partial, with Rieger anomaly, short stature, and insulinopenic diabetes mellitus
• Localized idiopathic lipoatrophy
• Localized lipoatrophy
• Localized lipoatrophy
• Localized lipoatrophy
• Localized lipoatrophy
• Localized lipodystrophy
• Loss of subcutaneous fat
• Loss of subcutaneous fat overlying triceps muscle
• Malabsorption of glucose
• Malabsorption of glucose
• Mandibuloacral dysostosis
• Mandibuloacral dysostosis
• Mandibuloacral dysplasia with type A lipodystrophy
• Mandibuloacral dysplasia with type B lipodystrophy
• Marfan's syndrome
• Membranous lipodystrophy
• Nakajo-Nishimura syndrome
• Panniculitis induced localized lipodystrophy
• Partial face-sparing lipodystrophy
• Perilipin 1 related familial partial lipodystrophy
• Post-inflammatory lipoatrophy
• PPARG-related familial partial lipodystrophy
• Progeroid and marfanoid aspect, lipodystrophy syndrome
• Semicircular lipoatrophy
• Severe neurodegenerative syndrome with lipodystrophy
• Widespread lipoatrophy

References to Index of Diseases and Injuries

The code E88.1 has the following ICD-10-CM references to the Index of Diseases and Injuries

• Inclusion Terms:
  • Lipodystrophy NOS
• Type 1 Excludes Notes:
  • Whipple's disease (@K90.81*)

Crosswalk Information

Similar Codes

This page was last updated on: 10/1/2023

« Previous Code